Acarix, confirms insurance coverage for the CADScor®System by key payors in Texas, considered the largest medical device market in the US. As a result, Acarix received first order of CADScor®System from a leading heart center in Texas, with additional orders expected from the region in early 2023. The Acarix CADScor®System has since its CPT III reimbursement code was activated in July 2022 secured insurance coverage by commercial payors and Medicare across key regions in the US.

Texas is considered the largest medical device market in the US with nearly 30 million inhabitants and Houston is home to the largest medical center in the world. With high volumes of patients with chest pains and risks of Coronary Artery Disease, there is a need for rapid cardiac diagnostics.